# Vascular Invasion Signatures in cfDNA Support Re-staging of Liver Cancer

> **NCT05540925** · — · COMPLETED · sponsor: **Eastern Hepatobiliary Surgery Hospital** · enrollment: 286 (actual)

## Conditions studied

- Carcinoma, Hepatocellular
- Hepatocellular Cancer
- Liver Cancer

## Interventions

- **PROCEDURE:** Liver resection

## Key facts

- **NCT ID:** NCT05540925
- **Lead sponsor:** Eastern Hepatobiliary Surgery Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 286 (ACTUAL)
- **Last updated:** 2022-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05540925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05540925, "Vascular Invasion Signatures in cfDNA Support Re-staging of Liver Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05540925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*